Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Mometasone
Drug ID BADD_D01490
Description Mometasone is a corticosteroid not currently used in medical products. [Mometasone furoate] however, is still in use.
Indications and Usage The inhaler is indicated for the maintenance treatment of asthma as prophylactic therapy. The nasal spray is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis.
Marketing Status Prescription; Discontinued
ATC Code D07AC13; D07XC03; R01AD09; R03BA07
DrugBank ID DB00764
KEGG ID D08227
MeSH ID D000068656
PubChem ID 441335
TTD Drug ID D03HYX
NDC Product Code 65162-891
Synonyms Mometasone Furoate | Furoate, Mometasone | Nasonex | Mometasone Furoate Monohydrate | Furoate Monohydrate, Mometasone | Monohydrate, Mometasone Furoate | Asmanex Twisthaler | Twisthaler, Asmanex | Asmanex | Rinelon | Elocon | Sch 32088 | Sch-32088 | Sch32088 | Mometasone
Chemical Information
Molecular Formula C22H28Cl2O4
CAS Registry Number 105102-22-5
SMILES CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Rhinitis22.07.03.006; 11.01.13.004--
Rhinitis allergic22.04.04.003; 10.01.04.003--
Rosacea23.02.08.001--Not Available
Secondary adrenocortical insufficiency05.01.02.003; 14.11.01.014--Not Available
Sinus congestion22.04.06.001--Not Available
Sinus headache22.02.05.023; 17.14.01.002--
Sinusitis22.07.03.007; 11.01.13.005--
Skin atrophy23.01.05.001--
Skin depigmentation23.05.02.002--Not Available
Skin discolouration23.03.03.005--Not Available
Skin striae23.01.05.002--Not Available
Telangiectasia24.03.03.003; 23.06.03.001--
Ulcer08.03.06.001--Not Available
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urinary tract infection11.01.14.004; 20.08.02.001--
Viral infection11.05.04.001--Not Available
Vomiting07.01.07.003--
Wheezing22.03.01.009--
Seasonal allergy22.04.04.008; 10.01.04.001; 06.04.01.013--Not Available
Contusion23.03.11.002; 15.03.01.008; 12.01.06.001; 24.07.06.001--
Large intestine polyp16.05.02.006; 07.20.01.010--Not Available
Nasal discomfort22.02.05.020--Not Available
Skin bacterial infection23.09.01.008; 11.02.01.007--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Type IV hypersensitivity reaction10.01.03.022--Not Available
Bacterial infection11.02.01.005--Not Available
Mediastinal disorder22.09.03.001--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages